Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
9.0 CHF
636.00 M CHF
6.57 B CHF
66.75 M
About LONZA N
Sector
Industry
CEO
Wolfgang Wienand
Website
Headquarters
Basel
Founded
1897
ISIN
CH0013841017
FIGI
BBG00NRVXZ89
Lonza Group AG engages in the supply of pharmaceutical, healthcare, and life science products. It operates through the following segments: Biologics, Small Molecules, Cell and Gene, Capsule and Health Ingredients, and Corporate. The Biologics segment serves as contract development and manufacturing partner for biopharmaceuticals, catering customers for all clinical and commercial manufacturing needs throughout the product lifecycle. The Small Molecules segment design, development, and manufacturing, with the ability to offer integrated drug substances to drug product solutions, including particle engineering and drug product packaging. The Cell and Gene segment develops, de-risk, commercializes, and scales their emerging therapies through its three business areas Cell and Gene Technologies, Bioscience, and Personalized Medicine. The Capsule and Health Ingredients segment provides innovative capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical companies. The Corporate segment refers to finance and accounting, legal, communication, information technology, and human resources functions. The company was founded on October 27, 1897 and is headquartered in Basel, Switzerland.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 0QNO is 612.6 CHF — it has increased by 1.22% in the past 24 hours. Watch LONZA GROUP AG CHF1 (REGD) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange LONZA GROUP AG CHF1 (REGD) stocks are traded under the ticker 0QNO.
0QNO stock has risen by 4.04% compared to the previous week, the month change is a 13.35% rise, over the last year LONZA GROUP AG CHF1 (REGD) has showed a 39.64% increase.
We've gathered analysts' opinions on LONZA GROUP AG CHF1 (REGD) future price: according to them, 0QNO price has a max estimate of 744.00 CHF and a min estimate of 600.00 CHF. Watch 0QNO chart and read a more detailed LONZA GROUP AG CHF1 (REGD) stock forecast: see what analysts think of LONZA GROUP AG CHF1 (REGD) and suggest that you do with its stocks.
0QNO reached its all-time high on Sep 7, 2021 with the price of 785.4 CHF, and its all-time low was 291.0 CHF and was reached on Apr 18, 2019. View more price dynamics on 0QNO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0QNO stock is 1.68% volatile and has beta coefficient of 0.83. Track LONZA GROUP AG CHF1 (REGD) stock price on the chart and check out the list of the most volatile stocks — is LONZA GROUP AG CHF1 (REGD) there?
Today LONZA GROUP AG CHF1 (REGD) has the market capitalization of 42.20 B, it has increased by 4.94% over the last week.
Yes, you can track LONZA GROUP AG CHF1 (REGD) financials in yearly and quarterly reports right on TradingView.
LONZA GROUP AG CHF1 (REGD) is going to release the next earnings report on Jul 23, 2025. Keep track of upcoming events with our Earnings Calendar.
0QNO earnings for the last half-year are 7.99 CHF per share, whereas the estimation was 6.84 CHF, resulting in a 16.75% surprise. The estimated earnings for the next half-year are 6.95 CHF per share. See more details about LONZA GROUP AG CHF1 (REGD) earnings.
LONZA GROUP AG CHF1 (REGD) revenue for the last half-year amounts to 3.52 B CHF, despite the estimated figure of 3.54 B CHF. In the next half-year revenue is expected to reach 3.52 B CHF.
0QNO net income for the last half-year is 307.00 M CHF, while the previous report showed 329.00 M CHF of net income which accounts for −6.69% change. Track more LONZA GROUP AG CHF1 (REGD) financial stats to get the full picture.
As of Feb 7, 2025, the company has 18.69 K employees. See our rating of the largest employees — is LONZA GROUP AG CHF1 (REGD) on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LONZA GROUP AG CHF1 (REGD) EBITDA is 1.49 B CHF, and current EBITDA margin is 26.36%. See more stats in LONZA GROUP AG CHF1 (REGD) financial statements.
Like other stocks, 0QNO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LONZA GROUP AG CHF1 (REGD) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LONZA GROUP AG CHF1 (REGD) technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LONZA GROUP AG CHF1 (REGD) stock shows the strong buy signal. See more of LONZA GROUP AG CHF1 (REGD) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.